Atrial Fibrillation D001281

Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Arrhythmias, Cardiac » Atrial Fibrillation

Description

Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.   MeSH

Hierarchy View


Phase 4 Indicated Drugs (76)


Organization Involved with Phase 4 Indications (200)

3M

Aarhus University

Ain Shams University

American Heart Association

Atrial Fibrillation Network

Autonomous University of Madrid

Axio Research Corporation

Bakulev Scientific Center of Cardiovascular Surgery

Bayer

Beijing CTSmed Co. Ltd

Bielanski Hospital

Biosense Webster, Inc.

Biotronik, Inc.

Cairo University

CAMC Health System

Canadian Institutes of Health Research (CIHR)

Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network

Cantonal Hospital of St. Gallen

Capital Medical University

Cardiome Pharma

Cardiovascular Consultants of Nevada

CardioVascular Research Foundation, Korea

Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland

Central South University

China Medical University

Chinese Academy of Medical Sciences

Chongqing Medical University

CHU Brabois

Clinica Universidad de Navarra

Creighton University

Dalhousie University

Dalian Medical University

Danish Heart Foundation

Diakonhjemmet Hospital

Duke University

Eastbourne General Hospital

eCardio Diagnostics

Electrophysiology Research Foundation

Escuela de Medicina y Ciencias de la Salud. Tecnológico de Monterrey. Monterrey. México

Federal University of Minas Gerais

Fundação de Amparo à Pesquisa do Estado de São Paulo

Fundación Pública Andaluza

Gennimatas Hospital, Athens

German Atrial Fibrillation Network

German Center for Cardiovascular Research e. V. (DZHK)

G.Gennimatas General Hospital

Ghent University

Gilead Sciences

Government of Canada

Government of Finland

Organization Involved with Phase 3 Indications (148)

Organization Involved with Other Experimental Indications (57)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.